EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Significance of Somatic Variants Involved in the Development of Pancreatic Cancer in Patients with HBOC-Associated Germline Variants

Koki Uchiyama iD, Hinano Nishikubo iD, Tomoya Sano, Yukina Furukawa, Dongheng Ma iD, Daiki Imanishi, Takemi Ishidate, Hongdong Gao, Canfeng Fan, Masakazu Yashiro iD

Genes · 2026

DOI: 10.3390/genes17091146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2026. Verfasst von Koki Uchiyama und 9 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Germ-Line Mutation, Hereditary Breast and Ovarian Cancer Syndrome. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hereditary cancer predisposition syndromes show a high risk of cancer development with germline pathogenic variants. Organ-specific surveillance has been recommended according to the causative gene. However, even among carriers of the same germline variants, developing cancer types are not always uniform. Tumor–normal paired comprehensive genomic profiling (CGP) enables the simultaneous assessment of germline and somatic variants in same patient. Correlations between germline variants and cancer types have been reported; however, the significance of combinations of a germline variant and somatic variants remain unclear in the development of cancer types.

Methods

In this study, we analyzed the correlation between pancreatic cancer and somatic variant patterns in patients with hereditary cancer predisposition syndrome, especially in patients with germline variants on BRCA1, BRCA2, or ATM.

Results

Here, we show the characteristic pancreatic cancer patterns according to co-existing somatic variants in patients with germline pathogenic variants. The tumor–normal paired genetic data from 18,732 patients who underwent tumor–normal paired CGP were analyzed, including 853 germline-positive patients registered in a Japanese database. The combination of the somatic TP53 variant and KRAS variant was closely correlated with the development of pancreatic cancer in patients with germline BRCA1, BRCA2, or ATM. In particular, the somatic KRAS variant was significantly associated with pancreatic cancer.

Conclusions

These findings suggest that pancreatic cancer of hereditary cancer syndromes might be associated with co-existing somatic KRAS variants within the pancreas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsGerm-Line MutationHereditary Breast and Ovarian Cancer SyndromeHumansFemaleGenetic Predisposition to DiseaseMaleBRCA2 ProteinBRCA1 ProteinTumor Suppressor Protein p53Ataxia Telangiectasia Mutated ProteinsMiddle AgedProto-Oncogene Proteins p21(ras)AgedAdult

Stichwörter der Autor:innen

ATMBRCA1BRCA2C-CATHBOCKRASTP53germline varianthereditary cancerpancreatic cancersomatic variant

Substanzen

BRCA2 ProteinBRCA1 ProteinTumor Suppressor Protein p53Ataxia Telangiectasia Mutated ProteinsBRCA2 protein, humanBRCA1 protein, humanATM protein, humanProto-Oncogene Proteins p21(ras)KRAS protein, humanTP53 protein, human

Autor:innen und Institutionen

  • Molecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan.
  • Cancer Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan.
  • Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan.

ORCID-Profile: Koki Uchiyama, Hinano Nishikubo, Dongheng Ma, Masakazu Yashiro

Zitieren

APA

Uchiyama, K., Nishikubo, H., Sano, T., Furukawa, Y., Ma, D., Imanishi, D., Ishidate, T., Gao, H., Fan, C., & Yashiro, M. (2026). The Significance of Somatic Variants Involved in the Development of Pancreatic Cancer in Patients with HBOC-Associated Germline Variants. Genes. https://doi.org/10.3390/genes17091146

Vancouver

Uchiyama K, Nishikubo H, Sano T, Furukawa Y, Ma D, Imanishi D, et al. The Significance of Somatic Variants Involved in the Development of Pancreatic Cancer in Patients with HBOC-Associated Germline Variants. Genes. 2026. doi:10.3390/genes17091146

BibTeX
@article{Uchiyama2026,
  author = {Uchiyama, Koki and Nishikubo, Hinano and Sano, Tomoya and Furukawa, Yukina and Ma, Dongheng and Imanishi, Daiki and Ishidate, Takemi and Gao, Hongdong and Fan, Canfeng and Yashiro, Masakazu},
  title = {The Significance of Somatic Variants Involved in the Development of Pancreatic Cancer in Patients with HBOC-Associated Germline Variants},
  journal = {Genes},
  year = {2026},
  doi = {10.3390/genes17091146}
}
Kostenlos starten →